Subgenomic flavivirus RNA as key target for live-attenuated vaccine development

J Virol. 2024 Jul 23;98(7):e0010023. doi: 10.1128/jvi.00100-23. Epub 2024 May 29.

Abstract

Live-attenuated flavivirus vaccines confer long-term protection against disease, but the design of attenuated flaviviruses does not follow a general approach. The non-coding, subgenomic flavivirus RNA (sfRNA) is produced by all flaviviruses and is an essential factor in viral pathogenesis and transmission. We argue that modulating sfRNA expression is a promising, universal strategy to finetune flavivirus attenuation for developing effective flavivirus vaccines of the future.

Keywords: Japanese encephalitis virus; West Nile virus; Zika virus; flavivirus; live-attenurated; noncoding RNA; sfRNA; tick-borne encephalitis virus; vaccines.

Publication types

  • Review

MeSH terms

  • Animals
  • Flavivirus Infections* / prevention & control
  • Flavivirus Infections* / virology
  • Flavivirus* / genetics
  • Flavivirus* / immunology
  • Humans
  • RNA, Viral* / genetics
  • Vaccine Development
  • Vaccines, Attenuated* / immunology
  • Viral Vaccines* / immunology

Substances

  • Vaccines, Attenuated
  • RNA, Viral
  • Viral Vaccines